The Liontrust US Opportunities Fund returned -4.21% in Q4 2022, compared with -0.31% by the S&P 500 Index and an average performance of -0.58% by funds in the IA North America sector.
US equity markets rallied in the final quarter of the year but returns remained negative for sterling-based investors, due to a weaker US dollar and stronger pound. Markets took solace from the fact that inflation, which had been running at high levels, appeared to be cooling, particularly for goods and energy. If this continues, as we expect, then it should allow the Federal Reserve to ease its aggressive interest rate hikes. Markets were concerned in 2022 that the Fed, which now looks to have been behind the curve on monetary policy, would push the US economy into a recession in its bid to tame inflation. The good news for investors is that we have seen an improvement in many of the sub-categories of inflation. Even in areas where inflation has yet to become an issue, most notably in services and shelter, the real-time data suggests that we will see improvement here too in the coming months, with rents coming down.
Bond yields, both nominal and real, have risen rapidly during 2022, which has hit equity market valuations, especially those of highly valued, high-growth companies. Unprofitable, high-growth software companies have seen some of the largest impacts on their valuations.
The earnings backdrop has also changed over the last year. After a period in which US corporates beat earnings expectations by some margin, quarterly earnings in 2022 were much more in line with historical averages and slipped below them in the latest quarter. The reception to earnings has also been muted, with the main issue being company guidance as companies anticipate a tougher year ahead. As we enter 2023, earnings have been revised down significantly and are currently giving the most negative reading outside of the 2008 and 2020 recessions.
The US Opportunities Fund underperformed both the S&P 500 Index and the wider peer group during Q4. There was considerable divergence between sector returns, with communication services and consumer discretionary stocks underperforming significantly. The more classically cyclical sectors of energy, industrials and materials outperformed. Energy stocks held up despite a weaker oil price. The biggest detractors in the portfolio during the period were two of our holdings that had disappointing earnings updates. These included Advance Drainage Systems, the waste-water pipe manufacturer, which highlighted end-market weakness; and Silicon Valley Bank, which has been severely impacted by a deterioration in the backdrop for venture capital, its core client base. Horizon Therapeutics, the biopharma company acquired by Amgen for $28bn, was a strong performer.
In terms of portfolio activity, we have made relatively minor changes to the portfolio and have focused on companies and industries that we think will be structural beneficiaries of the post-Covid world. We continue to believe that disruption, and particularly digital disruption, will remain the most important determinant of corporate success. We continue to search for companies that we believe will be drivers of this disruption (disruptors), help fuel it (enablers) or indeed benefit from it (embracers).
Discrete years' performance (%)**, to previous quarter-end:
|
Dec-22 |
Dec-21 |
Dec-20 |
Dec-19 |
Dec-18 |
Liontrust US Opportunities Acc |
-16.8 |
27.7 |
23.7 |
28.2 |
1.1 |
S&P 500 Index |
-8.2 |
29.3 |
14.1 |
25.7 |
1.0 |
IA North America |
-9.7 |
25.5 |
16.2 |
24.4 |
-1.4 |
Quartile |
4 |
2 |
1 |
1 |
2 |
*Source: FE Analytics as at 31.12.22
**Source: FE Analytics as at 31.12.22. Quartiles generated on 07.07.23
Key Risks
Disclaimer
This is a marketing communication. Before making an investment, you should read the relevant Prospectus and the Key Investor Information Document (KIID), which provide full product details including investment charges and risks. These documents can be obtained, free of charge, from www.liontrust.co.uk or direct from Liontrust. Always research your own investments. If you are not a professional investor please consult a regulated financial adviser regarding the suitability of such an investment for you and your personal circumstances.